Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Acute Cytokine Response to 30-Minute Exercise Bouts Before and After 8-Week Endurance Training in Individuals With Obesity. | J Clin Endocrinol Metab | 2023 | 36285617 | PubTator, text mining | PubMed |
ANK Therapeutic Prospects and Usefulness of PD-L1 and NK Activity as Biomarkers for Predicting Treatment Efficacy Revealed from the Treatment Course of Patients with HTLV-1-Associated Bronchioloalveolar Disease. | Cancer Med J | 2023 | 36282976 | PubTator, text mining | PubMed |
| Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer. | Cancer Med | 2023 | 36250429 | PubTator, text mining | PubMed |
| Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries. | Cell Death Differ | 2023 | 36195672 | PubTator, text mining | PubMed |
| Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics. | Stem Cell Rev Rep | 2023 | 36166137 | PubTator, text mining | PubMed |
| Identification of senescence-related molecular subtypes and key genes for prostate cancer. | Asian J Androl | 2023 | 36124532 | PubTator, text mining | PubMed |
| COL3A1: Potential prognostic predictor for head and neck cancer based on immune-microenvironment alternative splicing. | Cancer Med | 2023 | 36039012 | PubTator, text mining | PubMed |
| Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer. | Cancer Immunol Immunother | 2023 | 36002754 | PubTator, text mining | PubMed |
| The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. | Hepatology | 2023 | 35989535 | PubTator, text mining | PubMed |
| Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulation. | Haematologica | 2023 | 35899386 | PubTator, text mining | PubMed |
| Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor. | Clin Investig Arterioscler | 2023 | 35738949 | PubTator, text mining | PubMed |
| Immune checkpoints in T cells during oncogenic γ-herpesvirus infections. | J Med Virol | 2023 | 35524342 | PubTator, text mining | PubMed |
| Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses. | Clin Exp Med | 2023 | 35364779 | PubTator, text mining | PubMed |
| Prognostic factor identification by screening changes in differentially expressed genes in oral squamous cell carcinoma. | Oral Dis | 2023 | 33872434 | PubTator, text mining | PubMed |
| Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma. | J Oncol | 2022 | 37342680 | PubTator, text mining | PubMed |
| Manipulating NK cellular therapy from cancer to invasive fungal infection: promises and challenges. | Front Immunol | 2022 | 36969979 | PubTator, text mining | PubMed |
| A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA Vaccination. | Cancer Res Commun | 2022 | 36923303 | PubTator, text mining | PubMed |
| Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL. | Cancer Res Commun | 2022 | 36922932 | PubTator, text mining | PubMed |
| Scientific Basics of Personalized Medicine: Realities and Opportunities. | Her Russ Acad Sci | 2022 | 36744158 | PubTator, text mining | PubMed |
| A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. | Front Oncol | 2022 | 36713541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=32